Milligan David V Insider Trades

Insider Trading History

Track insider trading activity for Milligan David V. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals MDGL
Director
Holding Value $4.62M 9,470 shares
Last Trade
Jun 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$616k 9,470 shares
$65.06
$488.15
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals MDGL
Director
Holding Value $6.1M 12,489 shares
Last Trade
Jun 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.31M 12,489 shares
$105.08
$488.15
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals MDGL
Director
Holding Value $2.93M 6,000 shares
Last Trade
Jun 17, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$666k 6,000 shares
$111.06
$488.15
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals MDGL
Director
Holding Value $4.88M 10,000 shares
Last Trade
Jun 27, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1M 10,000 shares
$100.45
$488.15
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals MDGL
Director
Holding Value $0 0 shares
Last Trade
Nov 21, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.25M 20,000 shares
$112.54
$488.15
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals MDGL
Director
Holding Value $9.76M 20,000 shares
Last Trade
Nov 19, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.32M 10,000 shares
$131.60
$488.15
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals MDGL
Director
Holding Value $14.6M 30,000 shares
Last Trade
Nov 14, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.44M 10,000 shares
$143.72
$488.15
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals MDGL
Director
Holding Value $0 0 shares
Last Trade
Nov 14, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.44M 10,000 shares
$143.72
$488.15
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals MDGL
Director
Holding Value $0 0 shares
Last Trade
Sep 18, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.15M 20,000 shares
$207.30
$488.15
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals MDGL
Director
Holding Value $9.76M 20,000 shares
Last Trade
Sep 18, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.15M 20,000 shares
$207.30
$488.15
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals MDGL
Director
Holding Value $4.88M 10,000 shares
Last Trade
Jun 19, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.04M 10,000 shares
$303.79
$488.15
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals MDGL
Director
Holding Value $4.88M 10,000 shares
Last Trade
Jun 29, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$165k 10,000 shares
$16.46
$488.15
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals MDGL
Director
Holding Value $9.76M 20,000 shares
Last Trade
Jul 22, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.86k 20,000 shares
$0.34
$488.15
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals MDGL
Director
Holding Value $9.76M 20,000 shares
Last Trade
Jul 22, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.86k 20,000 shares
$0.34
$488.15

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up